NextGen Healthcare, Inc. provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen Patient Self Scheduling, NextGen Pay, and NextGen Virtual Visits; clinical care solutions, including NextGen Enterprise HER, NextGen Mobile, NextGen Office, NextGen Behavioral Health Suite, NextGen Orthopedic Suite, and QSIDental Web and QSIDental PM; and financial management solutions, such as NextGen Enterprise PM and NextGen Clearinghouse Solutions. It also provides population health solutions, consisting of NextGen Population Health Core, NextGen Population Health Value Management, and NextGen Population Health Patient Care Management; connected health solutions, comprising of NextGen Connect Integration Engine, NextGen Share, and NextGen Health Data Hub; and managed services, such as NextGen Managed Cloud Services and NextGen Revenue Cycle Management Services. . In addition, the company offers provides training, project management, functional and detailed specification preparation, configuration, testing, and installation services; and client and support services. Further, it provides consulting services, which include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves managed service organizations, independent physician associations, accountable care organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.
IPO Year:
Exchange: NASDAQ
Website: nextgen.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/28/2023 | $21.00 | Overweight | Cantor Fitzgerald |
| 4/12/2023 | $24.00 | Overweight | Stephens |
| 10/21/2022 | $20.00 | Neutral | Piper Sandler |
| 9/7/2022 | $20.00 | Hold | Truist |
| 5/6/2022 | $26.00 | Neutral → Buy | Guggenheim |
| 4/14/2022 | Neutral | Guggenheim | |
| 1/6/2022 | $22.00 | Mkt Perform → Outperform | SVB Leerink |
| 1/6/2022 | Market Perform → Outperform | SVB Leerink | |
| 7/30/2021 | $21.00 → $19.00 | Sector Perform | RBC Capital |
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
4 - NEXTGEN HEALTHCARE, INC. (0000708818) (Issuer)
Cantor Fitzgerald initiated coverage of NextGen Healthcare with a rating of Overweight and set a new price target of $21.00
Stephens initiated coverage of NextGen Healthcare with a rating of Overweight and set a new price target of $24.00
Piper Sandler resumed coverage of NextGen Healthcare with a rating of Neutral and set a new price target of $20.00
Truist initiated coverage of NextGen Healthcare with a rating of Hold and set a new price target of $20.00
Guggenheim upgraded NextGen Healthcare from Neutral to Buy and set a new price target of $26.00
Guggenheim initiated coverage of NextGen Healthcare with a rating of Neutral
SVB Leerink upgraded NextGen Healthcare from Mkt Perform to Outperform and set a new price target of $22.00
SVB Leerink upgraded NextGen Healthcare from Market Perform to Outperform
RBC Capital reiterated coverage of NextGen Healthcare with a rating of Sector Perform and set a new price target of $19.00 from $21.00 previously
JP Morgan initiated coverage of NextGen Healthcare with a rating of Neutral and set a new price target of $19.00
15-12G - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)
Raises Midpoint of Fiscal 2024 Revenue Guidance Range NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ending June 30, 2023. Fiscal 2024 First Quarter Highlights Total revenue was $178.2 million compared to $153.3 million for the same period a year ago, an increase of 16.2%. Recurring revenue was $163.4 million compared to $139.8 million for the same period a year ago, an increase of 16.9%. Non-recurring revenue was $14.8 million compared to $13.5 million for the same period a year ago, an increase of 9.5%. Fully diluted net income per shar
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative cloud-based healthcare technology solutions, today announced that it will release its fiscal 2024 first quarter results on Monday, July 24, 2023, after market close. In conjunction, the company will host a conference call to discuss the results and provide an update on its operations and strategy at 5 p.m. EST the same day. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 800-343-4136 or 203-518-9843 for international callers and referencing participant code NXGNQ124 approximately 15 minutes prior to the call. A recording of the event will be available at inv
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal fourth quarter and year ended March 31, 2023. Fiscal 2023 Fourth Quarter Highlights Total revenue was $178.6 million compared to $151.3 million for the same period a year ago, an increase of 18.0%. Recurring revenue was $161.9 million compared to $137.2 million for the same period a year ago, an increase of 18.0%. Non-recurring revenue was $16.6 million compared to $14.0 million for the same period a year ago, an increase of 18.4%. Fully diluted net loss per share was $0.38, which includes an accrual for the
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it will release its fiscal 2023 fourth quarter and full-year financial results ended March 31, 2023, on Tuesday, May 16, 2023, after market close. In conjunction, the company will host a conference call to discuss its results and provide an update on its operations and strategy at 5 p.m. EST the same day. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 800-343-4136 or 203-518-9843 for international callers and referencing participant code NXGNQ423 approximately 15 minutes prior to the call. A
Raises Full Year Revenue Guidance and Reaffirms Earnings NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal third quarter ended December 31, 2022. Fiscal 2023 Third Quarter Highlights Total revenue was $161.9 million compared to $149.7 million for the same period a year ago, an increase of 8%. Recurring revenue was $148.7 million compared to $134.5 million for the same period a year ago, an increase of 11%. Non-recurring revenue was $13.2 million compared to $15.2 million for the same period a year ago, a decrease of 14%. Bookings, which reflects annual contract
Highlights Well-Rounded Slate's Capital Allocation Acumen, Corporate Governance Experience, Relevant Sector Backgrounds, Transaction Expertise and Sorely Needed Ownership Perspectives Reiterates Its View That Stockholders Deserve New Leadership Following Years of Value Destruction Under Chair Michael Roth (26+ Years of Board Service) and CEO Marc Lautenbach (10+ Years of CEO and Board Service) Urges the Board to Avoid Initiating a Reactionary Director Refreshment or Employing Entrenchment Maneuvers to Insulate Messrs. Roth and Lautenbach Hestia Capital Management, LLC (collectively with its affiliates, "Hestia" or "we"), which is the third largest stockholder of Pitney Bowes, Inc. (NYSE:
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative cloud-based healthcare technology solutions, today announced that it will release its fiscal 2023 third quarter ended December 31, 2022, operating results on January 24, 2023, after market close, with a conference call to follow at 5 p.m. EST. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 800-343-4849 or 785-424-1699 for international callers and referencing participant code NXGNQ323 approximately 15 minutes prior to the call. A recording of the event will be available at investor.nextgen.com. It will be archived for 90 days. About NextGen Healthcare, Inc.
Raises Fiscal 2023 Financial Guidance NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal second quarter ended September 30, 2022. Fiscal 2023 Second Quarter Highlights Total revenue was $159.4 million compared to $149.3 million for the same period a year ago, an increase of 7%. Recurring revenue was $143.5 million compared to $135.6 million for the same period a year ago, an increase of 6%. Non-recurring revenue was $15.9 million compared to $13.7 million for the same period a year ago, an increase of 17%. Bookings, which reflects annual contract value, was $37.
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it will release its fiscal 2023 second quarter ended Sept. 30, 2022, operating results on Oct. 25, 2022, after market close, with a conference call to follow at 5 p.m. EST. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 800-343-5172 or 203-518-9848 for international callers and referencing participant code NXGNQ223 approximately 15 minutes prior to the call. A recording of the live webcast will be available on investor.nextgen.com after the call. It will be archived for 90 days. About NextGen
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ended June 30, 2022. Fiscal 2023 First Quarter Highlights Total revenue was $153.3 million compared to $146.1 million for the same period a year ago, or 5% growth. Recurring revenue was $139.8 million compared to $132.4 million for the same period a year ago, or 6% growth. Recurring revenue accounted for 91% of total revenue. Subscription services revenue was $42.8 million compared to $38.3 million for the same period a year ago, or 12% growth. This growth reflects solid demand for NextGen Office, Mob
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal second quarter ending September 30, 2023. Fiscal 2024 Second Quarter Highlights Total revenue was $176.4 million compared to $159.4 million for the same period a year ago, an increase of 10.6%. Recurring revenue was $161.3 million compared to $143.5 million for the same period a year ago, an increase of 12.4%. Non-recurring revenue was $15.1 million compared to $15.9 million for the same period a year ago, a decrease of 5.3%. Fully diluted net income per share was $0.07 compared to $0.20 for the same period
Attendees will Engage with Technology and Learn Best Practices for Maximizing Outcomes NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, will host a gathering of ambulatory healthcare professionals from around the country at UGM23. The user group meeting will be held November 29 - December 2, 2023, at Rosen Shingle Creek in Orlando, Florida. Approximately 2,000 attendees are expected to attend and engage with the latest healthcare technology solutions, learn from industry leaders and connect with peers. Themed "Maximize Outcomes," UGM23 will offer expert and client-led seminars on navigating regulatory challenges, opti
Fully Automated Ambient Listening Solution Summarizes Patient Visits Directly into EHR NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced the availability of NextGen™ Ambient Assist, an ambient listening solution that interprets patient-provider conversations in real time to summarize appointments and document care plans at unprecedented speeds. Ambient Assist delivers AI-generated subjective, objective, assessment, and plan (SOAP) notes directly into the electronic health record (EHR) for provider convenience. SOAP notes have long been used in many specialties to help providers organize their observatio
One of Nation's Largest Physical Therapy Networks Enters New Markets, Doubles Down on Healthcare Software Solution NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its extended agreement with Athletico Physical Therapy (Athletico), one of the nation's largest providers of the highest quality orthopedic rehabilitation services to communities, employers and athletes. NextGen® Enterprise electronic health record (EHR) and NextGen® Enterprise practice management (PM) will be used to optimize clinical and financial performance across Athletico's newly expanded footprint. Recognized as a national leader in e
Healthcare Technology Veteran Continues His Commitment to Advancing Innovation and Leadership Across the Industry NASHVILLE, Tenn., Sept. 12, 2023 /PRNewswire-PRWeb/ -- Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for healthcare organizations, is proud to announce that its Chief Financial Officer (CFO) Baxter Lee has been named to the Tennessee HIMSS Board of Directors for a one-year term beginning January 1, 2024. Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for healthcare organizations, is proud to announce that its Chief Financial Officer (CFO) Baxter Lee has been named to the Tennessee HIMSS Board of Directo
NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Summit Materials, Inc. (NYSE:SUM) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of SUM and Cementos Argos S.A. Under the terms of the proposed transaction, Cementos Argos S.A. will receive approximately 54.7 million shares of SUM stock and approximately $1.2 billion in cash, subject to closing adjustments. If you are a SUM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected]. BlackRock Capital Investment
NextGen Healthcare Shareholders to Receive $23.95 Per Share in Cash, a 46.4% Premium to Unaffected Stock Price Transaction to Accelerate NextGen Healthcare's Growth and Innovation as the Trusted Advisor to Healthcare Providers NextGen Healthcare, Inc. (NASDAQ:NXGN) ("NextGen Healthcare" or the "Company"), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it has entered into a definitive agreement to be acquired by Thoma Bravo, a leading software investment firm. Upon completion of the transaction, NextGen Healthcare will become a privately held company. This press release features multimedia. View the full release here: https://www.busi
Alliance combines best-in-class solutions to reduce staff burdens and improve patient experience HOUSTON and SAN FRANCISCO, Aug. 24, 2023 /PRNewswire/ -- NextGen Healthcare Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, and Luma Health, innovator of the market-leading Patient Success Platform™, announced an expanded alliance to equip ambulatory organizations nationwide with artificial intelligence (AI)-enhanced solutions for patient communications, beginning with intake and self-scheduling. NextGen® Patient Engage and NextGe
Alliance Combines Best-in-Class Solutions to Reduce Staff Burdens and Improve Patient Experience NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, and Luma Health, the market-leading Patient Success Platform™, today announced an expanded alliance to equip ambulatory organizations nationwide with artificial intelligence (AI)-enhanced solutions for patient communications, beginning with intake and self-scheduling. NextGen® Patient Engage and NextGen® Self-Scheduling powered by Luma will enable patients to conveniently engage with their care providers in more than 20 languages from their mobile devices. Integrated seamlessl
Colorado's First Community Mental Health Center Adopts Complete Behavioral Health Solution to Advance Care NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced Community Reach Center, a leading behavioral health and wellness provider in Colorado, has chosen NextGen® Enterprise electronic health record (EHR) and NextGen® Enterprise practice management (PM) to address mental health, substance abuse, and primary care needs across the Denver area. Community Reach Center operates the first and currently largest school-based therapy program in Colorado. Community Reach Center serves 22,000 children, teens, adult
SC 13G/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13G - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13G/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13G/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13G/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13D/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13D/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13D/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13D - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
SC 13G/A - NEXTGEN HEALTHCARE, INC. (0000708818) (Subject)
Health industry experts to provide counsel amid company's rapid growth and broader telemental health adoption Brightside Health, a telehealth platform that delivers life-changing mental health care to individuals with mild-to-severe clinical depression, anxiety, and other mood disorders, announced today the appointment of health industry experts Jeff Margolis as an independent board member and The Honorable David Shulkin, MD, as an advisor, effective October 1, 2022. Margolis and Secretary Shulkin will provide guidance to the organization as it expands and continues to deliver life-changing mental healthcare to all who need it, including those with elevated suicide risk. "We're pleased to
Industry veteran brings longstanding track record of growing innovative healthcare technology and service organizations from early-stage startup through category leadership DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of Jeff Margolis, a seasoned healthcare information technology executive and current Senior Advisor for Blackstone (NYSE:BX), to its Board of Directors. The appointment follows the company's $200 million financing round, which was led by Blackstone. "DNAnexus is already an exciting company at the intersection of healthcare and life sciences and the recent Blackstone investment will support the goal of becoming a ca
Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, today announced the retirement of its chief medical officer, Betty Rabinowitz, MD, FACP, effective December 31, 2021. Dr. Rabinowitz joined the company in 2017, following her role as one of the founders and former CEO of EagleDream Health, the cloud-based analytics and population management solution acquired by NextGen Healthcare. "Dr. Betty" as she is known in the industry, was appointed to the newly created chief medical officer role in 2018. Her lengthy healthcare career spans over 40 years and includes extensive clinical and academic experience. This press release features multimedia.
Sheldon Razin, the founder of NextGen Healthcare, Inc. (NASDAQ:NXGN) and its largest shareholder, issued the following statement with respect to the Company's 2021 Annual Meeting held today: On behalf of the Razin Group, I thank shareholders for their engagement over these past weeks. As the Company's founder and largest shareholder, I am proud of the growth and market expansion that the Company has achieved, and wish NextGen Healthcare's Board of Directors and management team success going forward. NextGen Healthcare has an outstanding portfolio of products and services that have transformed ambulatory care. With the appointment of the Company's new CEO, David Sides, and the talented an
Shareholders Approve the Company's Reincorporation into Delaware and the Elimination of Cumulative Voting in the Election of Directors Shareholders Elect All Nine of NextGen Healthcare's Director Nominees NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, today announced that at today's Annual Meeting, NextGen Healthcare shareholders approved: The reincorporation of NextGen Healthcare into Delaware The elimination of cumulative voting in the election of directors The election of all nine of the Company's director nominees to the Board of Directors, consisting of Craig A. Barbarosh, George H. Bristol, Darnell Dent, Julie D. Klapstei
Sides Brings Extensive Experience in Healthcare Software and Technology, and Proven Record Growing, Scaling and Diversifying Premier Global Healthcare Companies Appointment Builds on Strong Executive Team and Talented Employee Base Sides Joins NextGen Healthcare Director Slate for Upcoming Annual Meeting NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, today announced that David Sides has been appointed President and Chief Executive Officer, effective September 22. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210920005356/en/NextGen Healthcare President & CEO, David Side
Announces Governance Enhancements to Further Align with Best Practice Revises Director Slate to Include Only Individuals Who Are Committed to Serving All of NextGen Healthcare Shareholders' Best Interests Highlights Transformation that Has Positioned NextGen Healthcare for Significant Growth and Value Creation NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, today announced that it has filed preliminary proxy materials with the U.S. Securities and Exchange Commission in connection with its 2021 Annual Meeting of Shareholders currently scheduled to be held on October 13, 2021. All members of the NextGen Healthcare Board of Directors,
Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthcare Industry and Advance Board Diversity NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, announced the appointment of Geraldine McGinty, MD, MBA, FACR to its Board of Directors effective August 11, 2021, and that Pamela S. Puryear, PhD, MBA will join the Board's slate of director nominees for the 2021 Annual Meeting of Shareholders. With the Annual Meeting, James Malone will retire from the Board upon the conclusion of his service as a director. This press release features multimedia. View the full release here:
Board of Directors Establishes Executive Leadership and Board Oversight Committees and Commences CEO Search Company Affirms Fiscal Year 2022 Financial Outlook NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, today announced that the Company and Rusty Frantz have agreed to a mutual separation and that Mr. Frantz will no longer serve as President, Chief Executive Officer or a member of the NextGen Healthcare Board of Directors, effective immediately. An Executive Leadership Committee has been established to lead NextGen Healthcare on an interim basis while its next CEO is identified with the assistance of executive search firm Spencer S
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Structure Therapeutics Inc. (NASDAQ:GPCR) Structure Therapeutics recently released results from the Phase 1b multiple ascending dose (MAD) study of GSBR-1290 in healthy, overw
NextGen Healthcare (NASDAQ:NXGN) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.25 by 24 percent. This is a 24 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $176.42 million which missed the analyst consensus estimate of $176.95 million by 0.30 percent. This is a 10.65 percent increase over sales of $159.44 million the same period last year.
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Orchestra BioMed was granted FDA approval of an investigational device exemption to initiate its global BACKBEAT study evaluating
https://www.bloomberg.com/news/articles/2023-09-08/thoma-bravo-mulls-1-billion-private-credit-loan-for-nextgen-acquisition#xj4y7vzkgThoma Bravo is in discussions with private credit lenders about arranging roughly $1 billion of debt financing for its planned acquisition of NextGen Healthcare Inc., according to people with knowledge of the matter.A potential financing deal would reduce the amount of equity Thoma Bravo will need to put up for the acquisition but is not required for the takeover to close, said the people, who asked not to be named because details of the transaction are private
Truist Securities analyst Jailendra Singh maintains NextGen Healthcare (NASDAQ:NXGN) with a Hold and raises the price target from $18 to $23.95.
RBC Capital analyst Sean Dodge maintains NextGen Healthcare (NASDAQ:NXGN) with a Sector Perform and raises the price target from $17 to $23.95.
Gainers Palisade Bio, Inc. (NASDAQ:PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease. FOXO Technologies Inc. (NYSE:FOXO) gained 51.3% to $0.2164 after the company's FOXO LIFE subsidiary announced an agreement with Atrio, expanding its distribution through Atrio/Singular's sales network. iCoreConnect Inc. (NASDAQ:ICCT) shares climbed 46% to $9.83. iCoreConnect announced new version of its iCoreExchange encrypted HIPAA email and referral network. Marin Software Incorporated (NASDAQ:MRIN) rose 29% to $0.5535 after
Thoma Bravo, a software investment firm, agreed to acquire NextGen Healthcare Inc (NASDAQ:NXGN) for $23.95 per share in cash. Last month, NextGen Healthcare said it is exploring various strategic options, including possibly a company sale. Upon completion of the transaction, NextGen Healthcare will become a privately held company. The per-share purchase price represents a 46.4% premium to the Company's unaffected closing stock price on August 22 (the last trading day before published market speculation regarding a potential transaction involving the Company) and a 39.2% premium to the 30-day volume-weighted average price for the period ending September 1. The transaction is expected to
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. AeroVironment, Inc. (NASDAQ:AVAV) shares surged 28.7% to $122.65 after the company reported better-than-expected results for its first quarter. Mitek Systems, Inc. (NASDAQ:MITK) shares jumped 15% to $13.00 after the company posted first-quarter results and raised FY23 guidance. NextGen Healthcare, Inc. (NASDAQ:NXGN) gained 14.5% to $23.54 after the company agreed to be acquired by Thoma Bravo for $23.95 per share in cash. Gogo Inc. (NASDAQ:GOGO) rose 14.5% to $12.75. Gogo announced a $50 million share repurchase program. Hitek Global Inc. (NA